24/7 Market News Snapshot 17 July, 2025 – Rocket Pharmaceuticals, Inc. Common Stock (NASDAQ:RCKT)

July 17, 2025

DENVER, Colo., 17 July, 2025 (www.247marketnews.com) – (NASDAQ:RCKT) are discussed in this article.
Rocket Pharmaceuticals, Inc. (RCKT) has gained significant investor attention following a noteworthy surge in its stock prices, which opened today at $3.27 and is currently trading at approximately $3.395, reflecting an 18.71% increase from the previous close of $2.86. This robust performance, accompanied by a trading volume of 8.92 million shares, denotes a heightened investor interest and positive sentiment surrounding the company. Nevertheless, potential investors are advised to remain vigilant as rapid price escalations often lead to increased volatility. Analysts suggest monitoring resistance levels around $3.50 while considering broader market dynamics.

In a parallel development, Rocket Pharmaceuticals is facing a class action lawsuit over allegations of securities fraud. The Law Offices of Frank R. Cruz are spearheading the effort, which aims to hold the company accountable for reportedly misleading investors by failing to disclose critical safety-related adverse events (SAEs), including participant fatalities in clinical trials. The lawsuit contends that Rocket had altered the trial’s protocol to introduce a new immunomodulatory agent without prior notification to investors, undermining their trust in the company’s optimistic portrayals of its operations and future growth.

Affected stakeholders are encouraged to assess their involvement in this litigation before the lead plaintiff deadline of August 11, 2025. The Law Offices of Frank R. Cruz invite those who have experienced financial losses due to Rocket’s alleged misrepresentations to consider joining the class action to assert their rights. As the lawsuit progresses, it underscores the vital need for transparency and accountability in corporate practices, especially within the biotech industry, where the implications of such allegations can resonate deeply throughout the investment community.

Related news for (RCKT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.